Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-17-065212
Filing Date
2017-12-12
Accepted
2017-12-12 16:44:41
Documents
2
Period of Report
2017-12-11

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1663
2 POA DOCUMENT poa.txt EX-24.3_756525 3549
  Complete submission text file 0001209191-17-065212.txt   6613
Mailing Address 1601 TRAPELO ROAD SUITE 284 WALTHAM MA 02451
Business Address 1601 TRAPELO ROAD SUITE 284 WALTHAM MA 02451 617-600-7373
Minerva Neurosciences, Inc. (Issuer) CIK: 0001598646 (see all company filings)

EIN.: 260784194 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O MINERVA NEUROSCIENCES, INC. 1601 TRAPELO ROAD, SUITE 284 WALTHAM MA 02451
Business Address
Russell Richard E. (Reporting) CIK: 0001724897 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36517 | Film No.: 171252229